As shown in Figure 6c, the Kaplan–Meier curve comparing the effects on lifespan of Pio to the stimulator of insulin secretion glimepiride, which is extensively prescribed for the treatment of insulin resistance, demonstrated that patients on Pio have increased survival compared to those on glimepiride. The gene discussed is INS; the disease is Insulin resistance.